{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:29:15Z","timestamp":1788348555746,"version":"build-2803163510"},"reference-count":120,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.survophthal.2025.08.008","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:44:14Z","timestamp":1755495854000},"page":"361-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intraocular seeds in retinoblastoma: A review of classification, management, and outcomes"],"prefix":"10.1016","volume":"71","author":[{"given":"Mrittika","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis L.","family":"Munier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-5132","authenticated-orcid":false,"given":"Santosh G.","family":"Honavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.survophthal.2025.08.008_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijrobp.2007.11.004","article-title":"106Ruthenium brachytherapy for retinoblastoma","volume":"71","author":"Abouzeid","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.008_bib2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/archopht.122.9.1316","article-title":"Outcome following initial external beam radiotherapy in patients with Reese-ellsworth group vb retinoblastoma","volume":"122","author":"Abramson","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.008_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/13816810.2018.1443343","article-title":"Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma","volume":"39","author":"Abramson","year":"2018","journal-title":"Ophthalmic Genet"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.008_bib4","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/archopht.1981.03930020637003","article-title":"Simultaneous bilateral radiation for advanced bilateral retinoblastoma","volume":"99","author":"Abramson","year":"1981","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib5","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.3928\/01913913-20230110-01","article-title":"Intravitreal topotecan 90 \u00b5g for recurrent solid retinoblastoma tumors is effective and not toxic","volume":"60","author":"Abramson","year":"2023","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjophthalmol-2018-312037","article-title":"Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds","volume":"103","author":"Abramson","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","article-title":"Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results","volume":"96","author":"Abramson","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archopht.123.1.128-b","article-title":"Periocular chemotherapy for retinoblastoma: success with problems?","volume":"123","author":"Abramson","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib9","first-page":"0037","article-title":"ERG and OCT abnormalities in retinoblastoma after melphalan intravitreous injection","volume":"87","author":"Albuquerque","year":"2022","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02387425","article-title":"Vitreous seeds in retinoblastoma, clinical significance and ultrastructure","volume":"211","author":"Amemiya","year":"1979","journal-title":"Albrecht Von Graefes Arch F\u00fcR Klin und Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.008_bib11","article-title":"Outcomes of group d retinoblastoma with resistant vitreous seeds after integration of intravitreal chemotherapy to the treatment protocol","volume":"12","author":"Amin","year":"2020","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.008_bib12","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.ophtha.2017.04.015","article-title":"Vitreous seeds in retinoblastoma: clinicopathologic classification and correlation","volume":"124","author":"Amram","year":"2017","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000448718","article-title":"Acute hemorrhagic retinopathy following intravitreal melphalan injection for retinoblastoma report of two cases and technical modifications to enhance the prevention of retinal toxicity","volume":"3","author":"Aziz","year":"2017","journal-title":"Ocul Oncol Pathol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib14","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1097\/MPH.0000000000000167","article-title":"Anterior segment invasion in retinoblastoma: is it a risk factor for extraocular relapse?","volume":"36","author":"Baroni","year":"2014","journal-title":"J Pedia Hematol Oncol"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.008_bib15","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ophtha.2017.05.034","article-title":"Not all seeds are created equal: seed classification is predictive of outcomes in retinoblastoma","volume":"124","author":"Berry","year":"2017","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/pbc.24303","article-title":"Long-term outcomes of group d eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage","volume":"60","author":"Berry","year":"2013","journal-title":"Pediatr blood Cancer"},{"key":"10.1016\/j.survophthal.2025.08.008_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108439","article-title":"Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: efficacy, toxicity and stability in rabbits models and patients","volume":"204","author":"Bogan","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2025.08.008_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5935\/0004-2749.20140064","article-title":"Managing the consequences of aggressive conservative treatment for refractory retinoblastoma with vitreous seeding","volume":"77","author":"Brink","year":"2014","journal-title":"Arq Bras De Oftalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.exer.2013.01.002","article-title":"Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma","volume":"108","author":"Buitrago","year":"2013","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exer.2010.03.009","article-title":"Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment","volume":"91","author":"Buitrago","year":"2010","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.008_bib21","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/jamaophthalmol.2014.2324","article-title":"Stability of melphalan solution for intravitreal injection for retinoblastoma","volume":"132","author":"Buitrago","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.008_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bjo.2007.129981","article-title":"Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation","volume":"93","author":"Chan","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib23","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.08-2737","article-title":"A phase I study of periocular topotecan in children with intraocular retinoblastoma","volume":"50","author":"Chantada","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1076\/opge.25.1.37.28996","article-title":"Activity of topotecan in retinoblastoma","volume":"25","author":"Chantada","year":"2004","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.survophthal.2025.08.008_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-016-0204-6","article-title":"Diffuse chorioretinal atrophy after a single standard low-dose intravitreal melphalan injection in a child with retinoblastoma: a case report","volume":"16","author":"Chao","year":"2016","journal-title":"BMC Ophthalmol"},{"issue":"31","key":"10.1016\/j.survophthal.2025.08.008_bib26","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1200\/JCO.2004.00.1883","article-title":"Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir","volume":"23","author":"Ch\u00e9vez-Barrios","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/13816810.2010.499888","article-title":"106Ruthenium brachytherapy for ciliary recurrence with supraciliary effusion in retinoblastoma","volume":"31","author":"Chhablani","year":"2010","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.008_bib28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/IAE.0b013e3181669781","article-title":"Vitreous seeding from retinal astrocytoma in three cases","volume":"28","author":"Cohen","year":"2008","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5507\/bp.2011.068","article-title":"Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: alternative retinoblastoma treatment","volume":"156","author":"Darsova","year":"2012","journal-title":"Biomed Pap"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.008_bib30","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ophtha.2006.02.047","article-title":"Late-onset retinoblastoma in a well-functioning fellow eye","volume":"113","author":"de Jong","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2025.08.008_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109026","article-title":"Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: implications for retinoblastoma treatment","volume":"218","author":"Del Sole","year":"2022","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1755-3768.1961.tb00269.x","article-title":"Present therapeutic resources in retinoblastoma","volume":"39","author":"Ericson","year":"1961","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/bjophthalmol-2012-302495","article-title":"Indocyanine Green enhanced transpupillary thermotherapy in combination with ophthalmic artery chemosurgery for retinoblastoma","volume":"97","author":"Francis","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.008_bib34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ophtha.2015.01.017","article-title":"The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan","volume":"122","author":"Francis","year":"2015","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.008_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jamaophthalmol.2017.4600","article-title":"Risk of extraocular extension in eyes with retinoblastoma receiving intravitreous chemotherapy","volume":"135","author":"Francis","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2016.12.015","article-title":"Efficacy and toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.008_bib37","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.ophtha.2017.04.010","article-title":"Retinoblastoma vitreous seed clouds (class 3): a comparison of treatment with ophthalmic artery chemosurgery with or without intravitreous and periocular chemotherapy","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.008_bib38","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ophtha.2016.02.036","article-title":"Classification of vitreous seeds in retinoblastoma: correlations with patient, tumor, and treatment characteristics","volume":"123","author":"Francis","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.008_bib39","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jamaophthalmol.2015.3119","article-title":"Anterior ocular toxicity of intravitreous melphalan for retinoblastoma","volume":"133","author":"Francis","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICB.0000000000000262","article-title":"Intravitreal melphalan as salvage therapy for refractory retinal and subretinal retinoblastoma","volume":"10","author":"Francis","year":"2016","journal-title":"Retin cases Brief Rep"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.008_bib41","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ophtha.2014.03.028","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study","volume":"121","author":"Francis","year":"2014","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib42","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2014.414","article-title":"Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma","volume":"132","author":"Ghassemi","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.008_bib43","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","article-title":"Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma","volume":"130","author":"Ghassemi","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.008_bib44","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1167\/iovs.18-24359","article-title":"Targeting the platelet-derived growth factor-beta stimulatory circuitry to control retinoblastoma seeds","volume":"59","author":"Goldsmith","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.008_bib45","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/bjo.2006.091223","article-title":"Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?","volume":"90","author":"Gombos","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.008_bib46","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41433-020-0898-9","article-title":"A 20-year audit of retinoblastoma treatment outcomes","volume":"34","author":"G\u00fcnd\u00fcz","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2025.08.008_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/11206721231163619","article-title":"Follow-up of retinoblastoma using RetCam fluorescein angiography and correlation with clinical findings","author":"G\u00fcnd\u00fcz","year":"2023","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.008_bib48","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2353\/ajpath.2010.091270","article-title":"Live free or die: tales of homeless (cells) in cancer","volume":"177","author":"Horbinski","year":"2010","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib49","first-page":"858","article-title":"Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay","volume":"78","author":"Inomata","year":"1987","journal-title":"Jpn J Cancer Res"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib50","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MPH.0000000000001176","article-title":"Outcomes of proton beam radiation therapy for retinoblastoma with vitreous seeds","volume":"40","author":"Jung","year":"2018","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"14","key":"10.1016\/j.survophthal.2025.08.008_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.62.14.8","article-title":"Intravitreal HDAC inhibitor belinostat effectively eradicates vitreous seeds without retinal toxicity in vivo in a rabbit retinoblastoma model","volume":"62","author":"Kaczmarek","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0301-4738.154369","article-title":"Retinoblastoma: achieving new standards with methods of chemotherapy","volume":"63","author":"Kaliki","year":"2015","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.008_bib53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ceo.13964","article-title":"Aqueous seeding in intraocular retinoblastoma: a review","volume":"49","author":"Kaliki","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.008_bib54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jjco\/hyg113","article-title":"Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding","volume":"33","author":"Kaneko","year":"2003","journal-title":"Jpn J Clin Oncol"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.008_bib55","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0161-6420(85)34105-2","article-title":"Tumor seeding in ocular fine needle aspiration biopsy","volume":"92","author":"Karcioglu","year":"1985","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.008_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3928\/01913913-20161116-01","article-title":"Intraocular pressure changes following intravitreal melphalan and topotecan for the treatment of retinoblastoma with vitreous seeding","volume":"54","author":"Karl","year":"2017","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib57","first-page":"1","article-title":"Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin","volume":"47","author":"Kim","year":"2010","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.008_bib58","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/archopht.1996.01100140539004","article-title":"Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma","volume":"114","author":"Kingston","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10384-020-00743-2","article-title":"Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma","volume":"64","author":"Kiratli","year":"2020","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib60","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5301\/ejo.5000921","article-title":"Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma","volume":"27","author":"Kiratli","year":"2017","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib61","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.ophtha.2011.02.005","article-title":"Intravitreal methotrexate for retinoblastoma","volume":"118","author":"Kivel\u00e4","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.18240\/ijo.2020.02.09","article-title":"Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma","volume":"13","author":"Liang","year":"2020","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib63","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0161-6420(98)91617-7","article-title":"Treatment of retinoblastoma vitreous base seeding","volume":"105","author":"Madreperla","year":"1998","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.008_bib64","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archophthalmol.2011.130","article-title":"Periocular topotecan for intraocular retinoblastoma","volume":"129","author":"Mallipatna","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib65","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ophtha.2013.09.011","article-title":"Management and outcome of retinoblastoma with vitreous seeds","volume":"121","author":"Manjandavida","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.008_bib66","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/bjophthalmol-2011-300517","article-title":"Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity","volume":"96","author":"Marr","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/bjophthalmol-2011-300051","article-title":"Ultrasound biomicroscopy evaluation of anterior extension in retinoblastoma: a clinicopathological study","volume":"96","author":"Moulin","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.05.005","article-title":"Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. \"Alive, with good vision and no comorbidity\"","volume":"73","author":"Munier","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib69","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.008_bib70","first-page":"1663","article-title":"Aqueous seeding: fall of the ultimate intraocular retinoblastoma sanctuary by a new in situ chemotherapy technique","volume":"56","author":"Munier","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000453617","article-title":"Intracameral chemotherapy (melphalan) for aqueous seeding in retinoblastoma: bicameral injection technique and related toxicity in a pilot case study","volume":"3","author":"Munier","year":"2017","journal-title":"Ocul Oncol Pathol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib72","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/13816810.2014.973045","article-title":"Classification and management of seeds in retinoblastoma ellsworth lecture ghent August 24th 2013","volume":"35","author":"Munier","year":"2014","journal-title":"Ophthalmic Genet"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib74","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3928\/01913913-20070301-06","article-title":"Systemic metastasis following hyphema drainage in an unsuspected retinoblastoma","volume":"44","author":"Murthy","year":"2007","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.survophthal.2025.08.008_bib76","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2147\/OTT.S370878","article-title":"Spotlight on targeted chemotherapy in retinoblastoma: safety, efficacy, and patient outcomes","author":"Naseripour","year":"2022","journal-title":"OncoTargets Ther"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.008_bib77","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2017.4603","article-title":"Intracameral topotecan hydrochloride for anterior chamber seeding of retinoblastoma","volume":"135","author":"Paez-Escamilla","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.008_bib78","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ajo.2008.12.014","article-title":"Sudden dispersion of retinoblastoma shortly after initial chemotherapy treatment","volume":"147","author":"Parness-Yossifon","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib79","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/bjophthalmol-2017-310641","article-title":"Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma","volume":"102","author":"Rao","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib80","volume":"472","author":"Reese","year":"1951"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib81","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaapos.2016.05.009","article-title":"Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes","volume":"20","author":"Say","year":"2016","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.008_bib82","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/pbc.24356","article-title":"Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma","volume":"60","author":"Schaiquevich","year":"2013","journal-title":"Pediatr blood Cancer"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000520952","article-title":"Combination of brachytherapy and intravitreal chemotherapy in the treatment of retinoblastoma with vitreous seeding","volume":"8","author":"Schl\u00fcter","year":"2022","journal-title":"Ocul Oncol Pathol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.008_bib84","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3928\/23258160-20161004-12","article-title":"Portable optical coherence tomography detection or confirmation of ophthalmoscopically invisible or indeterminate active retinoblastoma","volume":"47","author":"Seider","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib85","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bjo.79.2.194","article-title":"Intravitreal chemotherapy for recurrent retinoblastoma in an only eye","volume":"79","author":"Seregard","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2024.04.022","article-title":"Intravitreal topotecan for vitreous seeds in retinoblastoma: a long-term review of 91 eyes","author":"Sen","year":"2024","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.008_bib87","first-page":"1548","article-title":"Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre","volume":"104","author":"Shields","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.008_bib88","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","article-title":"Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds","volume":"129","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.008_bib89","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IAE.0000000000000903","article-title":"Intravitreous chemotherapy for active vitreous seeding from retinoblastoma","volume":"36","author":"Shields","year":"2016","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib90","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/eye.2012.175","article-title":"Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy","volume":"27","author":"Shields","year":"2013","journal-title":"Eye"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.008_bib91","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/S0161-6420(00)00427-9","article-title":"Vitrectomy in eyes with unsuspected retinoblastoma","volume":"107","author":"Shields","year":"2000","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2025.08.008_bib92","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0002-9394(02)01348-X","article-title":"Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation","volume":"133","author":"Shields","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib93","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archopht.120.4.460","article-title":"Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma","volume":"120","author":"Shields","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib94","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ophtha.2015.09.040","article-title":"Diffuse anterior retinoblastoma with globe salvage and visual preservation in 3 consecutive cases","volume":"123","author":"Shields","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2025.08.008_bib95","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","article-title":"Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.008_bib96","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.008_bib97","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","article-title":"The international classification of retinoblastoma predicts chemoreduction success","volume":"113","author":"Shields","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib98","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ophtha.2012.07.067","article-title":"Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation","volume":"120","author":"Shields","year":"2013","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2025.08.008_bib99","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0161-6420(93)31667-2","article-title":"Plaque radiotherapy in the management of retinoblastoma: use as a primary and secondary treatment","volume":"100","author":"Shields","year":"1993","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.008_bib100","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1080\/10837450.2016.1265557","article-title":"Solution stability of Captisol-stabilized melphalan (Evomela) versus propylene glycol-based melphalan hydrochloride injection","volume":"23","author":"Singh","year":"2018","journal-title":"Pharm Dev Technol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib101","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bjophthalmol-2011-300829","article-title":"Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds","volume":"96","author":"Smith","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.008_bib102","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bjophthalmol-2013-303188","article-title":"Evaluating the risk of extraocular tumor spread following intravitreal injection therapy for retinoblastoma: a systematic review","volume":"97","author":"Smith","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib103","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1177\/1078155220904410","article-title":"Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: implementation and outcomes of a new chemotherapy protocol","volume":"26","author":"Solana-Altabella","year":"2020","journal-title":"J Oncol Pharm Pract"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.008_bib104","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1167\/iovs.17-22111","article-title":"Anterior chamber invasion in retinoblastoma: not an indication for adjuvant chemotherapy","volume":"58","author":"Sreelakshmi","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bjo-2022-322492","article-title":"Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity","volume":"108","author":"Stathopoulos","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib106","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ophtha.2021.01.014","article-title":"OCT imaging of Schlemm\u2019s canal invasion in a retinoblastoma patient","volume":"128","author":"Stathopoulos","year":"2021","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2025.08.008_bib107","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1080\/13816810.2022.2141801","article-title":"Retinal and optic nerve relapse in retinoblastoma secondary to epiretinal and epipapillary vitreous seeds implantation documented by optical coherence tomography","volume":"43","author":"Stathopoulos","year":"2022","journal-title":"Ophthalmic Genet"},{"issue":"12","key":"10.1016\/j.survophthal.2025.08.008_bib108","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.4103\/ijo.IJO_737_18","article-title":"Periocular topotecan for vitreous seeds in retinoblastoma","volume":"66","author":"Sthapit","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib109","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10384-015-0378-0","article-title":"Intravitreal injection of melphalan for intraocular retinoblastoma","volume":"59","author":"Suzuki","year":"2015","journal-title":"Jpn J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2025.08.008_bib110","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis","volume":"118","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2025.08.008_bib111","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/01.iae.0000225350.83931.f6","article-title":"Vitreoretinal complications of retinoblastoma treatment","volume":"26","author":"Tawansy","year":"2006","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib112","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/bjophthalmol-2021-318892","article-title":"Retinoblastoma seeds: impact on American joint committee on cancer clinical staging","volume":"107","author":"Tomar","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.08.008_bib113","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ophtha.2022.04.022","article-title":"Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter Registry-Based study","volume":"129","author":"Tomar","year":"2022","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.survophthal.2025.08.008_bib114","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3928\/23258160-20151008-07","article-title":"Intravitreal lower-dose (20 \u00b5g) melphalan for persistent or recurrent retinoblastoma vitreous seeds","volume":"46","author":"Tuncer","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"11","key":"10.1016\/j.survophthal.2025.08.008_bib115","first-page":"1230","article-title":"Study on conservative treatment of retinoblastoma--effect of intravitreal injection of melphalan on the rabbit retina","volume":"99","author":"Ueda","year":"1995","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.survophthal.2025.08.008_bib116","first-page":"e41","article-title":"Asteroid hyalosis simulating vitreous seeds in a patient with retinoblastoma","volume":"56","author":"Williams","year":"2019","journal-title":"J Pedia Ophthalmol Strabismus"},{"issue":"1","key":"10.1016\/j.survophthal.2025.08.008_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-019-1059-4","article-title":"Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients","volume":"19","author":"Xue","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.08.008_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.696787","article-title":"Safety and efficacy of intravitreal chemotherapy (melphalan) to treat vitreous seeds in retinoblastoma","volume":"12","author":"Yousef","year":"2021","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.08.008_bib119","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000491432","article-title":"Precision intravitreal chemotherapy for localized vitreous seeding of retinoblastoma","volume":"5","author":"Yu","year":"2019","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.survophthal.2025.08.008_fur1","first-page":"14","article-title":"Vitreous injection therapy of melphalan for retinoblastoma","author":"Suzuki","year":"2011","journal-title":"InXVth Biannu Meet Int Soc Ocul Oncol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725001390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T18:03:25Z","timestamp":1768845805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625725001390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":120,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0039625725001390"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.08.008","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraocular seeds in retinoblastoma: A review of classification, management, and outcomes","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}